EN DE
STOCK COMPARISON

HCA Healthcare vs Sarana Meditama Metropolitan: Fair Value & Quality

Both stocks run through our valuation models. Here is how HCA Healthcare (HCA) and Sarana Meditama Metropolitan (SAME) compare, as of Sep 24, 2026.

As of Sep 24, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: HCA Healthcare trades at $436 versus a fair value of $593 (+36%), while Sarana Meditama Metropolitan trades at IDR 290 versus IDR 42 (-85%).
HCA Healthcare
HCA · USD · Health Care
+36%
upside to fair value
undervalued
Price$436
Fair Value$593
Quality70/100
Sarana Meditama Metropolitan
SAME.JK · IDR · Health Care
-85%
upside to fair value
overvalued
PriceIDR 290
Fair ValueIDR 42
Quality49/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

HCA HealthcareSarana Meditama Metropolitan
Valuation
15.0×P/E (TTM)256.6×
1.32×P/S (TTM)2.62×
Negative equityP/B1.31×
9.1×EV/EBITDA15.3×
1.18×PEGn/a
+35.8%Fair value upside−85.3%
0.7%Dividend yieldn/a
$2.94Dividend per sharen/a
Profitability
15%Operating margin4%
1.12×EBIT margin trend (5Y)3.53×
Negative equityReturn on equity1%
12%Return on assets1%
Growth
4%Revenue growth (YoY)9%
7.9%Avg. growth/yr (3Y)10.1%
8.0%Avg. growth/yr (5Y)29.7%
+16.7%Value creation/yr+3.6%
Balance & size
5.3×Interest coverage (EBIT/interest)1.4×
Negative equityDebt / equity0.13×
$101BMarket cap$498M
healthyGrowth qualityexpensive

HCA Healthcare leads: 9 to 3 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

HCA Healthcareof which business quality 66 · market factors 47 Sarana Meditama Metropolitanof which business quality 49 · market factors 34
ProfitabilityMargins and returns on capital today
76
17
Quality GrowthAre margins and returns improving?
61
52
CashflowEarnings quality: real cash, not paper profit
62
47
Fin. StrengthBalance sheet, leverage, solvency risk
39
52
InvestmentDisciplined investing over empire-building
75
60
Low VolatilityCalm price path (market factor)
58
62
MomentumPrice trend over the last 3–12 months (market factor)
44
26
52W MomentumDistance to the 52-week high (market factor)
42
16
Net IssuanceShare count: buybacks or dilution?
100
81

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyHCA HealthcarePrice $436Sarana Meditama MetropolitanPrice IDR 290
DCF Models+41%above the price$615-72%below the priceIDR 80
Earnings-Based-34%below the price$289-90%below the priceIDR 28
Dividend Discount-88%below the price$53.85n/a
Multiples+54%above the price$673-82%below the priceIDR 52
Asset-Basedn/a-49%below the priceIDR 148
Growth DCF+47%above the price$643-75%below the priceIDR 73
Economic Profit-4%close to the price$419-73%below the priceIDR 77
Growth Earnings+16%above the price$506-85%below the priceIDR 42
Minimum-88%below the price$53.85-90%below the priceIDR 28
Maximum+54%above the price$673-49%below the priceIDR 148
Median+16%above the price$506-75%below the priceIDR 73
Geometric mean-16%below the price$366-78%below the priceIDR 64

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

HCA Healthcare: 6 of 23 models see the stock below the current price.

Sarana Meditama Metropolitan: 21 of 22 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

HCA Healthcare
Price $436
Fair Value $593
Bear $306Bull $841
Sarana Meditama Metropolitan
Price IDR 290
Fair Value IDR 42
Bear IDR 26Bull IDR 55

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

HCA Healthcare · Health Care

Quality score70 · Top 25%
Fair value upside+36% · Top 25%

Sarana Meditama Metropolitan · Health Care

Quality score49 · below median
Fair value upside-85% · bottom 25%

Bottom line

As of Sep 24, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: HCA Healthcare trades at $436 versus a fair value of $593 (+36%), while Sarana Meditama Metropolitan trades at IDR 290 versus IDR 42 (-85%).

HCA Healthcare has the higher quality score (70/100).

Open HCA Healthcare live analysis →
HCA Healthcare · Sarana Meditama Metropolitan

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to HCA Healthcare

Microsoft vs NvidiaApple vs MicrosoftNvidia vs Taiwan Semiconductor ManufacturingApple vs Taiwan Semiconductor Manufacturing

Related to Sarana Meditama Metropolitan

Alphabet Inc Class C vs Meta PlatformsCisco Systems vs NvidiaMicrosoft vs Taiwan Semiconductor ManufacturingApple vs Cisco Systems
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.